Skip to content

Sarcopenia: European consensus on definition and diagnosis

Alfonso José Cruz-Jentoft, Jean‐Pierre Baeyens, Jürgen Martin Bauer, Yves Boirie‌, Tommy Cederholm, Francesco Landi, Finbarr C. Martin, Jean‐Pierre Michel, Yves Rolland, Stéphane Michel Schneider, Eva Topinková, Maurits F. J. Vandewoude, Mauro Musa Zamboni

Age and Ageing · 2010 · 12,022 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Cruz-Jentoft, A. J., Baeyens, J., Bauer, J. M., Boirie‌ Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J., Rolland, Y., Schneider, S. M., Topinková, E., Vandewoude, M. F. J., & Zamboni, M. M. (2010). Sarcopenia: European consensus on definition and diagnosis. Age and Ageing, 39(4), 412–423. https://doi.org/10.1093/ageing/afq034

In text: (Cruz-Jentoft et al., 2010)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia. EWGSOP included representatives from four participant organisations, i.e. the European Geriatric Medicine Society, the European Society for Clinical Nutrition and Metabolism, the International Association of Gerontology and Geriatrics-European Region and the International Association of Nutrition and Aging. These organisations endorsed the findings in the final document. The group met and addressed the following questions, using the medical literature to build evidence-based answers: (i) What is sarcopenia? (ii) What parameters define sarcopenia? (iii) What variables reflect these parameters, and what measurement tools and cut-off points can be used? (iv) How does sarcopenia relate to cachexia, frailty and sarcopenic obesity? For the diagnosis of sarcopenia, EWGSOP recommends using the presence of both low muscle mass + low muscle function (strength or performance). EWGSOP variously applies these characteristics to further define conceptual stages as 'presarcopenia', 'sarcopenia' and 'severe sarcopenia'. EWGSOP reviewed a wide range of tools that can be used to measure the specific variables of muscle mass, muscle strength and physical performance. Our paper summarises currently available data defining sarcopenia cut-off points by age and gender; suggests an algorithm for sarcopenia case finding in older individuals based on measurements of gait speed, grip strength and muscle mass; and presents a list of suggested primary and secondary outcome domains for research. Once an operational definition of sarcopenia is adopted and included in the mainstream of comprehensive geriatric assessment, the next steps are to define the natural course of sarcopenia and to develop and define effective treatment.

  1. Frailty in Older Adults: Evidence for a Phenotype2001
  2. The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons1991
  3. Sarcopenia: revised European consensus on definition and diagnosis2018
  4. Studies of Illness in the Aged1963
  5. A Short Physical Performance Battery Assessing Lower Extremity Function: Association With Self-Reported Disability and Prediction of Mortality and Nursing Home Admission1994

Metadata from OpenAlex (CC0). Citations are generated from the published record.